Myelofibrosis (combination with ruxolitinib)| XPORT-MF-034
Indication: Myelofibrosis
Title: A Study to Evaluate Safety and Efficacy of Selinexor in Combination With Ruxolitinib in Participants With Myelofibrosis
Drug: Selinexor
Please Visit clinicaltrials.gov for more information about this study.
Phase I | Phase II | Phase III |
---|---|---|
Phase I | Phase II | Phase III |